ProfileGDS4718 / 227064_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 89% 88% 97% 91% 89% 88% 90% 90% 90% 88% 88% 92% 89% 88% 86% 89% 89% 88% 87% 86% 90% 90% 90% 90% 88% 90% 91% 91% 88% 91% 82% 87% 90% 89% 90% 92% 89% 89% 90% 97% 90% 87% 89% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.0182389
GSM549102patient 115, normal, homogenized [OPG study]8.8153188
GSM549104patient 119, normal, homogenized [OPG study]10.836597
GSM549108patient 138, normal, homogenized [OPG study]9.2167191
GSM549119patient 077, normal, homogenized [OPG study]8.9643189
GSM549133patient 032, cancer, homogenized [OPG study]9.0550188
GSM549139patient 042, cancer, homogenized [OPG study]9.2250490
GSM549099patient 107, normal, homogenized [OPG study]9.1103190
GSM549109patient 139, normal, homogenized [OPG study]9.2550590
GSM549110patient 046, normal, homogenized [OPG study]8.9265288
GSM549114patient 063, normal, homogenized [OPG study]9.0539188
GSM549122patient 082, normal, homogenized [OPG study]9.6019392
GSM549134patient 033, cancer, homogenized [OPG study]9.0239789
GSM549136patient 036, cancer, homogenized [OPG study]8.9341288
GSM549140patient 044, cancer, homogenized [OPG study]8.6771386
GSM549111patient 047, normal, homogenized [OPG study]9.0629889
GSM549113patient 057, normal, homogenized [OPG study]9.1641889
GSM549132patient 031, cancer, homogenized [OPG study]8.9009388
GSM549137patient 038, cancer, homogenized [OPG study]8.7429187
GSM549142patient 047, cancer, homogenized [OPG study]8.183586
GSM549100patient 110, normal, homogenized [OPG study]9.1111890
GSM549107patient 135, normal, homogenized [OPG study]9.3315590
GSM549115patient 068, normal, homogenized [OPG study]9.4154190
GSM549116patient 072, normal, homogenized [OPG study]9.247290
GSM549120patient 078, normal, homogenized [OPG study]8.8836588
GSM549131patient 030, cancer, homogenized [OPG study]9.2416790
GSM549118patient 074, normal, homogenized [OPG study]9.4534891
GSM549129patient 027, cancer, homogenized [OPG study]9.158991
GSM549123patient 088, normal, homogenized [OPG study]8.9049188
GSM549124patient 006, cancer, homogenized [OPG study]9.1842991
GSM549126patient 015, cancer, homogenized [OPG study]8.1100682
GSM549128patient 025, cancer, homogenized [OPG study]8.7921787
GSM549103patient 117, normal, homogenized [OPG study]9.1736490
GSM549117patient 073, normal, homogenized [OPG study]9.2147889
GSM549138patient 041, cancer, homogenized [OPG study]9.2161190
GSM549141patient 045, cancer, homogenized [OPG study]9.6029292
GSM549130patient 028, cancer, homogenized [OPG study]8.9042789
GSM549101patient 111, normal, homogenized [OPG study]9.0515689
GSM549105patient 128, normal, homogenized [OPG study]9.2175490
GSM549106patient 134, normal, homogenized [OPG study]11.259897
GSM549112patient 048, normal, homogenized [OPG study]9.2236790
GSM549125patient 011, cancer, homogenized [OPG study]8.7319387
GSM549127patient 024, cancer, homogenized [OPG study]8.9539789
GSM549135patient 035, cancer, homogenized [OPG study]9.4266591